Samumed Announces Publication of Phase 2 Data on Lorecivivint, Now in Pivotal Trials for Knee Osteoarthritis

    NEXT STORY
    Generex Subsidiary NGIO Advances COVID-19 Vaccine Program with the Manufacturing of Patent-Pending Ii-Key-SARS-CoV-2 Peptides
    PREV STORY
    Checkpoint Therapeutics to Host Virtual Annual Meeting of Stockholders
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeyondSpring Appoints Richard J. Daly as Chief Operating Officer to Lead the Transition to Commercialization

    Daly Brings Significant Commercial and Business Development Experience with Global Pharmaceutical CompaniesNEW YORK, Aug. ...

    author_avatar
    NASDAQ Market News

    CORRECTION: MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten

    author_avatar
    NASDAQ Market News

    Wearable Injectors Market: By Global Industry Analysis, Size, Share, Growth, Trends, Forecast 2016 – 2025

    LAS VEGAS, Nov. 23, 2017 (GLOBE NEWSWIRE) -- Global Wearable Injectors are also known ...

    author_avatar
    NASDAQ Market News